Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSC | P53634 | 4/20 | 0.63 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | MPO | P05164 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | BLM | P54132 | 1/20 | 0.58 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.58 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.58 |
| ▸ | TACR1 | P25103 | 2/20 | 0.57 |
| ▸ | HTR2A | P28223 | 2/20 | 0.50 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.50 |
| ▸ | HTR1A | P08908 | 1/20 | 0.50 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.50 |
| ▸ | HTR1D | P28221 | 1/20 | 0.50 |
| ▸ | HTR1B | P28222 | 1/20 | 0.50 |
| ▸ | HTR2C | P28335 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3421789 | 0.90 | CTSC (0.60) | CTSCMEN1KMT2AKDM4EMAPT | |
| SCHEMBL475351 | 0.88 | MAPT (0.74) | MEN1KMT2AKDM4EMAPTLMNA | |
| SCHEMBL289044 | 0.88 | MAPT (0.74) | MEN1KMT2AKDM4EMAPTLMNA | |
| Dl-Tryptophan SCHEMBL11461241 | 0.86 | KMT2A (0.76) | CTSCMEN1KMT2AKDM4EMAPT | |
| Tryptophan SCHEMBL2229691 | 0.86 | KMT2A (0.76) | CTSCMEN1KMT2AKDM4EMAPT | |
| Dl-Tryptophan SCHEMBL23924440 | 0.86 | KMT2A (0.76) | CTSCMEN1KMT2AKDM4EMAPT | |
| Dl-Tryptophan SCHEMBL2229687 | 0.86 | KMT2A (0.76) | CTSCMEN1KMT2AKDM4EMAPT | |
| SCHEMBL5065255 | 0.84 | KDM4E (0.65) | CTSCMEN1KMT2AKDM4EMAPT | |
| Methionine SCHEMBL8860166 | 0.84 | MEN1 (0.49) | CTSCMEN1KMT2AKDM4EMAPT | |
| SCHEMBL3401965 | 0.84 | KDM4E (0.64) | MEN1KMT2AKDM4EMAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024131837-A1 | ENGINEERED NUCLEASE WITH HIGH SALT TOLERANCE | WUXI BIOLOGICS (SHANGHAI) CO., LTD. (CN) | 2024-06-27 | — | — | WO | claimed |
| WO-2020069862-A1 | PREPARATION OF AMINO ACIDS FROM THEIR AMINO NITRILES | EVONIK OPERATIONS GMBH (DE) | 2020-04-09 | — | — | WO | claimed |
| WO-2020069859-A1 | SALT-FREE PREPARATION OF AMINO ACIDS FROM THEIR AMINO NITRILES | EVONIK OPERATIONS GMBH (DE) | 2020-04-09 | — | — | WO | claimed |
| EP-3632895-A1 | SALT-FREE PRODUCTION OF AMINO ACIDS FROM THEIR AMINONITRILES | Evonik Operations GmbH (DE) | 2020-04-08 | — | — | EP | claimed |
| EP-3632896-A1 | PRODUCTION OF AMINO ACIDS FROM THEIR AMINONITRILES | Evonik Operations GmbH (DE) | 2020-04-08 | — | — | EP | claimed |
| WO-2024131837-A1 | ENGINEERED NUCLEASE WITH HIGH SALT TOLERANCE | WUXI BIOLOGICS (SHANGHAI) CO., LTD. (CN) | 2024-06-27 | — | — | WO | disclosed |
| US-20240093248-A1 | CELLS AND METHOD OF CELL CULTURE | PFIZER INC. (US) | 2024-03-21 | — | — | US | disclosed |
| US-11718864-B2 | Cells and method of cell culture | PFIZER INC. (US) | 2023-08-08 | — | — | US | disclosed |
| WO-2023126510-A1 | MONOOXYGENASE MUTANTS FOR BIOSYNTHESIS OF 2,6-BIS(HYDROXYMETHYL)PYRIDINE AND A METHOD FOR PREPARATION OF 2,6-BIS(HYDROXYMETHYL)PYRIDINE USING THE SAID MONOOXYGENASE MUTANTS | VIO CHEMICALS AG (CH) | 2023-07-06 | — | — | WO | disclosed |
| US-20220386649-A1 | COMPOSITION COMPRISING AMINO ACIDS AND A LIPID MATRIX FOR NON-MAMMALIAN MONOGASTRIC ANIMALS AND USE THEREOF | VETAGRO INTERNATIONAL S.R.L. (IT) | 2022-12-08 | — | — | US | disclosed |
| EP-4003051-A1 | GRANULAR COMPOSITION COMPRISING AMINO ACIDS AND PHYTOCOMPOUNDS EMBEDDED IN A LIPID MATRIX FOR NON-MAMMALIAN MONOGASTRIC ANIMALS AND USE THEREOF | Vetagro International S.r.l. (IT) | 2022-06-01 | — | — | EP | disclosed |
| US-10947596-B2 | Compositions and methods for identification, assessment, prevention, and treatment of cancer using NFS1 biomarkers and modulators | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2021-03-16 | — | — | US | disclosed |
| WO-1999047173-A2 | CARRIER FOR IN VIVO DELIVERY OF A THERAPEUTIC AGENT | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 1999-09-23 | — | — | WO | disclosed |
| WO-1999015662-A9 | TELOMERE REPEAT BINDING FACTORS AND DIAGNOSTIC AND THERAPEUTIC USE THEREOF | UNIV ROCKEFELLER (US) | 1999-07-08 | — | — | WO | disclosed |
| WO-1999021995-A1 | TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES USING MODULATORS OF THE INTERACTION OF APP AND A POLYPEPTIDE DEFINING A PI DOMAIN | THE ROCKEFELLER UNIVERSITY (US) | 1999-05-06 | — | — | WO | disclosed |
| WO-1999015662-A1 | TELOMERE REPEAT BINDING FACTORS AND DIAGNOSTIC AND THERAPEUTIC USE THEREOF | THE ROCKEFELLER UNIVERSITY (US) | 1999-04-01 | — | — | WO | disclosed |
| WO-1999009056-A1 | INHIBITION OF HIV-1 REPLICATION USING D-AMINO ACID PEPTIDES | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 1999-02-25 | — | — | WO | disclosed |
| WO-1999009199-A2 | ELONGATION FACTOR-2 KINASE (EF-2 KINASE) AND METHODS OF USE THEREFOR | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 1999-02-25 | — | — | WO | disclosed |
| CN-1161001-A | Lipid metabolism-improving agent | KYOWA HAKKO KOGYO KK (JP) | 1997-10-01 | — | — | CN | disclosed |
| US-5559142-A | NUTRIENTS | JAROWSKI CHARLES I (US) | 1996-09-24 | — | — | US | disclosed |